Duloxetine in the treatment of generalized anxiety disorder
Alan Wright, Chad VanDenBergCenter for Clinical Research, Mercer University, Atlanta, GA, USAAbstract: Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) which is FDA approved for the treatment of generalized anxiety disorder (GAD) in doses of 30 mg to 120 mg daily. Duloxetine has be...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-08-01
|
| Series: | International Journal of General Medicine |
| Online Access: | http://www.dovepress.com/duloxetine-in-the-treatment-generalized-anxiety-disorder-a3461 |